Olmesartan‐based monotherapy vs combination therapy in hypertension: A meta‐analysis based on age and chronic kidney disease status

Antihypertensive monotherapy is often insufficient to control blood pressure (BP). Several recent guidelines advocate for initial combination drug therapy in many patients. This meta‐analysis of seven randomized, double‐blind studies (N = 5888) evaluated 8 weeks of olmesartan medoxomil (OM)–based si...

Descripción completa

Detalles Bibliográficos
Autores principales: Deedwania, Prakash, Weber, Michael, Reimitz, Paul‐Egbert, Bakris, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765479/
https://www.ncbi.nlm.nih.gov/pubmed/29067756
http://dx.doi.org/10.1111/jch.13103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765479/
https://www.ncbi.nlm.nih.gov/pubmed/29067756
http://dx.doi.org/10.1111/jch.13103

Ejemplares similares